MXPA06015188A - Analisis dimensional de conjugados sacaridos con cromatrografia de permeacion en gel y cromatografia de exclusion de tamano con deteccion mediante fotometria de dispersion de luz de angulos multiples. - Google Patents
Analisis dimensional de conjugados sacaridos con cromatrografia de permeacion en gel y cromatografia de exclusion de tamano con deteccion mediante fotometria de dispersion de luz de angulos multiples.Info
- Publication number
- MXPA06015188A MXPA06015188A MXPA06015188A MXPA06015188A MXPA06015188A MX PA06015188 A MXPA06015188 A MX PA06015188A MX PA06015188 A MXPA06015188 A MX PA06015188A MX PA06015188 A MXPA06015188 A MX PA06015188A MX PA06015188 A MXPA06015188 A MX PA06015188A
- Authority
- MX
- Mexico
- Prior art keywords
- color
- tone
- elements
- clarity
- group
- Prior art date
Links
- 150000001720 carbohydrates Chemical class 0.000 title abstract 4
- 238000004141 dimensional analysis Methods 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract description 27
- 230000008569 process Effects 0.000 claims abstract description 9
- 239000003086 colorant Substances 0.000 claims description 192
- 230000000875 corresponding effect Effects 0.000 claims description 18
- 230000002596 correlated effect Effects 0.000 claims description 17
- 229920006395 saturated elastomer Polymers 0.000 claims description 14
- 239000011159 matrix material Substances 0.000 claims description 12
- 238000001429 visible spectrum Methods 0.000 claims description 11
- 230000013011 mating Effects 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 238000012800 visualization Methods 0.000 claims description 6
- 238000010276 construction Methods 0.000 claims description 5
- 239000004744 fabric Substances 0.000 claims description 4
- 238000010422 painting Methods 0.000 claims description 4
- 238000012938 design process Methods 0.000 claims description 3
- 239000003973 paint Substances 0.000 claims description 2
- 238000005227 gel permeation chromatography Methods 0.000 abstract 3
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 238000001514 detection method Methods 0.000 abstract 1
- 238000000569 multi-angle light scattering Methods 0.000 abstract 1
- 238000005375 photometry Methods 0.000 abstract 1
- 238000001542 size-exclusion chromatography Methods 0.000 abstract 1
- 230000006870 function Effects 0.000 description 6
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 6
- 239000010931 gold Substances 0.000 description 6
- 229910052737 gold Inorganic materials 0.000 description 6
- 230000007704 transition Effects 0.000 description 6
- 238000005259 measurement Methods 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- 238000011179 visual inspection Methods 0.000 description 5
- 238000005034 decoration Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- YWXYYJSYQOXTPL-SLPGGIOYSA-N isosorbide mononitrate Chemical compound [O-][N+](=O)O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 YWXYYJSYQOXTPL-SLPGGIOYSA-N 0.000 description 3
- 235000012544 Viola sororia Nutrition 0.000 description 2
- 241001106476 Violaceae Species 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 241001248531 Euchloe <genus> Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000004456 color vision Effects 0.000 description 1
- 238000009500 colour coating Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000013178 mathematical model Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- ORFSSYGWXNGVFB-UHFFFAOYSA-N sodium 4-amino-6-[[4-[4-[(8-amino-1-hydroxy-5,7-disulfonaphthalen-2-yl)diazenyl]-3-methoxyphenyl]-2-methoxyphenyl]diazenyl]-5-hydroxynaphthalene-1,3-disulfonic acid Chemical compound COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C4=C(C=C3)C(=CC(=C4N)S(=O)(=O)O)S(=O)(=O)O)O)OC)N=NC5=C(C6=C(C=C5)C(=CC(=C6N)S(=O)(=O)O)S(=O)(=O)O)O.[Na+] ORFSSYGWXNGVFB-UHFFFAOYSA-N 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000010981 turquoise Substances 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Spectrometry And Color Measurement (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0413868.1A GB0413868D0 (en) | 2004-06-21 | 2004-06-21 | Dimensional anlaysis of saccharide conjugates |
| PCT/IB2005/002532 WO2006000920A2 (en) | 2004-06-21 | 2005-06-21 | Dimensional analysis of saccharide conjugates with gpc & sec-mals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA06015188A true MXPA06015188A (es) | 2007-03-27 |
Family
ID=32750313
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA06015188A MXPA06015188A (es) | 2004-06-21 | 2005-06-21 | Analisis dimensional de conjugados sacaridos con cromatrografia de permeacion en gel y cromatografia de exclusion de tamano con deteccion mediante fotometria de dispersion de luz de angulos multiples. |
| MX2011011568A MX344621B (es) | 2004-06-21 | 2006-12-20 | Analisis dimensional de conjugados sacaridos con cromatografia de permeacion en gel y cromatografia de exclusion de tamaño con deteccion mediante fotometria de dispersion de luz de angulos multiples. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2011011568A MX344621B (es) | 2004-06-21 | 2006-12-20 | Analisis dimensional de conjugados sacaridos con cromatografia de permeacion en gel y cromatografia de exclusion de tamaño con deteccion mediante fotometria de dispersion de luz de angulos multiples. |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US8163296B2 (cg-RX-API-DMAC10.html) |
| EP (2) | EP2374473B1 (cg-RX-API-DMAC10.html) |
| JP (5) | JP2008503716A (cg-RX-API-DMAC10.html) |
| CN (1) | CN1976725B (cg-RX-API-DMAC10.html) |
| AU (1) | AU2005256961B2 (cg-RX-API-DMAC10.html) |
| BR (1) | BRPI0512281A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2571565C (cg-RX-API-DMAC10.html) |
| ES (2) | ES2443465T3 (cg-RX-API-DMAC10.html) |
| GB (1) | GB0413868D0 (cg-RX-API-DMAC10.html) |
| MX (2) | MXPA06015188A (cg-RX-API-DMAC10.html) |
| NZ (1) | NZ552449A (cg-RX-API-DMAC10.html) |
| RU (1) | RU2422156C2 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2006000920A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
| GB0413868D0 (en) * | 2004-06-21 | 2004-07-21 | Chiron Srl | Dimensional anlaysis of saccharide conjugates |
| HUE045482T2 (hu) | 2005-06-27 | 2019-12-30 | Glaxosmithkline Biologicals Sa | Immunogén készítmény |
| AR064642A1 (es) | 2006-12-22 | 2009-04-15 | Wyeth Corp | Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi |
| TW201009337A (en) * | 2008-05-30 | 2010-03-01 | Intervet Int Bv | Analytical method to monitor vaccine potency and stability |
| EP2437882A4 (en) | 2009-06-01 | 2016-11-23 | Waters Technologies Corp | HYBRID MATERIAL FOR CHROMATOGRAPHY SEPARATIONS |
| US8195405B2 (en) * | 2009-06-30 | 2012-06-05 | Wyatt Technology Corporation | Method for characterizing reversible association of macromolecules at high concentration |
| PT2493498T (pt) | 2009-10-30 | 2017-05-24 | Glaxosmithkline Biologicals Sa | Purificação de sacáridos capsulares de staphylococcus aureus tipo 5 e tipo 8 |
| EP4023330A1 (en) * | 2009-12-15 | 2022-07-06 | Waters Technologies Corporation | Device and methods for performing size exclusion chromatography |
| CN107029223A (zh) * | 2010-05-26 | 2017-08-11 | 西莱克塔生物科技公司 | 合成纳米载体联合疫苗 |
| EP3834927B1 (en) | 2010-07-26 | 2026-03-25 | Waters Technologies Corporation | Method for preparing a superficially porous material |
| US12623205B2 (en) | 2010-07-26 | 2026-05-12 | Waters Technologies Corporation | Superficially porous materials comprising a substantially nonporous hybrid core having narrow particle size distribution |
| CA2808975C (en) | 2010-08-23 | 2018-10-30 | Wyeth Llc | Stable formulations of neisseria meningitidis rlp2086 antigens |
| KR101584871B1 (ko) | 2010-09-10 | 2016-01-22 | 와이어쓰 엘엘씨 | 네이세리아 메닝기티디스 orf2086 항원의 비-지질화된 변이체 |
| CA2865745C (en) | 2012-03-09 | 2018-01-09 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
| US10481164B2 (en) | 2012-03-26 | 2019-11-19 | Amgen Inc. | Method for using light scattering in real time to directly monitor and control impurity removal in purification processes |
| CA2903716C (en) | 2013-03-08 | 2019-04-09 | Pfizer Inc. | Immunogenic fusion polypeptides |
| RU2662968C2 (ru) | 2013-09-08 | 2018-07-31 | Пфайзер Инк. | Иммуногенная композиция против neisseria meningitidis (варианты) |
| KR20190049940A (ko) | 2015-02-19 | 2019-05-09 | 화이자 인코포레이티드 | 나이세리아 메닌지티디스 조성물 및 그의 방법 |
| CN109890413B (zh) | 2016-09-02 | 2024-04-16 | 赛诺菲巴斯德股份有限公司 | 脑膜炎奈瑟氏菌疫苗 |
| IL267709B2 (en) | 2016-12-30 | 2025-04-01 | Vaxcyte Inc | Polypeptide-antigen conjugates with unnatural amino acids |
| US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
| SG11201906519RA (en) | 2017-01-31 | 2019-08-27 | Pfizer | Neisseria meningitidis compositions and methods thereof |
| CN109459523B (zh) | 2017-09-06 | 2022-11-08 | 上海绿谷制药有限公司 | 一种测定酸性糖可溶性盐重均分子量和含量的方法 |
| CN109459504B (zh) * | 2017-09-06 | 2022-05-27 | 绿谷(上海)医药科技有限公司 | 一种测定聚古罗糖醛酸硫酸酯盐重均分子量和含量的方法 |
| CA3155669A1 (en) | 2019-09-27 | 2021-04-01 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| JP7409055B2 (ja) * | 2019-12-05 | 2024-01-09 | 株式会社島津製作所 | 検出器の出力を補正する方法、および多角度光散乱検出器 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4057685A (en) | 1972-02-02 | 1977-11-08 | Abbott Laboratories | Chemically modified endotoxin immunizing agent |
| US4356170A (en) | 1981-05-27 | 1982-10-26 | Canadian Patents & Development Ltd. | Immunogenic polysaccharide-protein conjugates |
| US4673574A (en) | 1981-08-31 | 1987-06-16 | Anderson Porter W | Immunogenic conjugates |
| US4459286A (en) | 1983-01-31 | 1984-07-10 | Merck & Co., Inc. | Coupled H. influenzae type B vaccine |
| US4663160A (en) | 1983-03-14 | 1987-05-05 | Miles Laboratories, Inc. | Vaccines for gram-negative bacteria |
| US4761283A (en) | 1983-07-05 | 1988-08-02 | The University Of Rochester | Immunogenic conjugates |
| US4808700A (en) | 1984-07-09 | 1989-02-28 | Praxis Biologics, Inc. | Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers |
| JPH01125328A (ja) | 1987-07-30 | 1989-05-17 | Centro Natl De Biopreparados | 髄膜炎菌ワクチン |
| NL8802046A (nl) | 1988-08-18 | 1990-03-16 | Gen Electric | Polymeermengsel met polyester en alkaansulfonaat, daaruit gevormde voorwerpen. |
| DE3841091A1 (de) | 1988-12-07 | 1990-06-13 | Behringwerke Ag | Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung |
| CA2006700A1 (en) | 1989-01-17 | 1990-07-17 | Antonello Pessi | Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines |
| AU651949B2 (en) | 1989-07-14 | 1994-08-11 | American Cyanamid Company | Cytokine and hormone carriers for conjugate vaccines |
| IT1237764B (it) | 1989-11-10 | 1993-06-17 | Eniricerche Spa | Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici. |
| SE466259B (sv) | 1990-05-31 | 1992-01-20 | Arne Forsgren | Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal |
| ATE128628T1 (de) | 1990-08-13 | 1995-10-15 | American Cyanamid Co | Faser-hemagglutinin von bordetella pertussis als träger für konjugierten impfstoff. |
| US5153312A (en) | 1990-09-28 | 1992-10-06 | American Cyanamid Company | Oligosaccharide conjugate vaccines |
| IT1262896B (it) | 1992-03-06 | 1996-07-22 | Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini. | |
| IL102687A (en) | 1992-07-30 | 1997-06-10 | Yeda Res & Dev | Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them |
| NZ311000A (en) | 1995-06-07 | 1999-04-29 | Smithkline Beecham Biolog | Vaccine comprising a polysaccharide antigen-carrier protein conjugate and a free carrier protein |
| US6299881B1 (en) | 1997-03-24 | 2001-10-09 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts |
| GB9713156D0 (en) | 1997-06-20 | 1997-08-27 | Microbiological Res Authority | Vaccines |
| US7018637B2 (en) | 1998-02-23 | 2006-03-28 | Aventis Pasteur, Inc | Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines |
| CN1263510C (zh) | 1998-08-19 | 2006-07-12 | 巴克斯特健康护理股份有限公司 | 多糖－蛋白质缀合物或寡糖－蛋白质缀合物、其制备方法及其应用 |
| CA2366152A1 (en) | 1999-03-19 | 2000-09-28 | Smithkline Beecham Biologicals S.A. | Streptococcus pneumoniae vaccine |
| WO2000061761A2 (en) | 1999-04-09 | 2000-10-19 | Techlab, Inc. | Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines |
| ES2588917T3 (es) | 2000-01-17 | 2016-11-07 | Glaxosmithkline Biologicals Sa | Vacuna de VME suplementada contra meningococo |
| GB0007432D0 (en) | 2000-03-27 | 2000-05-17 | Microbiological Res Authority | Proteins for use as carriers in conjugate vaccines |
| MXPA03000822A (es) | 2000-07-27 | 2004-11-01 | Childrens Hosp & Res Ct Oak | Vacunas para proteccion de espectro amplio contra enfermedades causadas por neisseria meningitidis. |
| GB0103170D0 (en) | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
| CA2435681C (en) * | 2001-01-23 | 2011-06-21 | Aventis Pasteur | Multivalent meningococcal polysaccharide-protein conjugate vaccine |
| AU2002309706A1 (en) | 2001-05-11 | 2002-11-25 | Aventis Pasteur, Inc. | Novel meningitis conjugate vaccine |
| GB0115176D0 (en) * | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
| EP2351579B1 (en) * | 2002-10-11 | 2016-09-21 | Novartis Vaccines and Diagnostics S.r.l. | Polypeptide vaccines for broad protection against hypervirulent meningococcal lineages |
| DK1587537T3 (da) * | 2003-01-30 | 2012-07-16 | Novartis Ag | Injicerbare vacciner mod multiple meningococ-serogrupper |
| ES2397923T3 (es) * | 2003-10-02 | 2013-03-12 | Novartis Ag | Vacunas líquidas para múltiples serogrupos meningocócicos |
| GB0323103D0 (en) | 2003-10-02 | 2003-11-05 | Chiron Srl | De-acetylated saccharides |
| GB0408978D0 (en) * | 2004-04-22 | 2004-05-26 | Chiron Srl | Meningococcal fermentation for preparing conjugate vaccines |
| GB0413868D0 (en) * | 2004-06-21 | 2004-07-21 | Chiron Srl | Dimensional anlaysis of saccharide conjugates |
-
2004
- 2004-06-21 GB GBGB0413868.1A patent/GB0413868D0/en not_active Ceased
-
2005
- 2005-06-21 CN CN2005800204436A patent/CN1976725B/zh not_active Expired - Lifetime
- 2005-06-21 NZ NZ552449A patent/NZ552449A/en not_active IP Right Cessation
- 2005-06-21 ES ES05770612.9T patent/ES2443465T3/es not_active Expired - Lifetime
- 2005-06-21 AU AU2005256961A patent/AU2005256961B2/en not_active Expired
- 2005-06-21 BR BRPI0512281-3A patent/BRPI0512281A/pt not_active Application Discontinuation
- 2005-06-21 WO PCT/IB2005/002532 patent/WO2006000920A2/en not_active Ceased
- 2005-06-21 JP JP2007516078A patent/JP2008503716A/ja not_active Withdrawn
- 2005-06-21 EP EP11163751.8A patent/EP2374473B1/en not_active Expired - Lifetime
- 2005-06-21 ES ES11163751.8T patent/ES2688796T3/es not_active Expired - Lifetime
- 2005-06-21 EP EP05770612.9A patent/EP1778291B1/en not_active Expired - Lifetime
- 2005-06-21 MX MXPA06015188A patent/MXPA06015188A/es active IP Right Grant
- 2005-06-21 US US11/630,545 patent/US8163296B2/en active Active
- 2005-06-21 CA CA2571565A patent/CA2571565C/en not_active Expired - Lifetime
- 2005-06-21 RU RU2007102016/15A patent/RU2422156C2/ru active IP Right Revival
-
2006
- 2006-12-20 MX MX2011011568A patent/MX344621B/es unknown
-
2011
- 2011-09-02 JP JP2011192126A patent/JP2011246490A/ja not_active Withdrawn
-
2012
- 2012-04-24 US US13/454,658 patent/US20120207781A1/en not_active Abandoned
-
2014
- 2014-03-11 JP JP2014047555A patent/JP6218327B2/ja not_active Expired - Lifetime
-
2015
- 2015-07-21 JP JP2015143718A patent/JP2015180707A/ja active Pending
-
2017
- 2017-04-21 JP JP2017084454A patent/JP6661568B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US8163296B2 (en) | 2012-04-24 |
| RU2422156C2 (ru) | 2011-06-27 |
| CN1976725A (zh) | 2007-06-06 |
| JP6218327B2 (ja) | 2017-10-25 |
| JP6661568B2 (ja) | 2020-03-11 |
| JP2011246490A (ja) | 2011-12-08 |
| JP2015180707A (ja) | 2015-10-15 |
| EP2374473A1 (en) | 2011-10-12 |
| RU2007102016A (ru) | 2008-07-27 |
| AU2005256961B2 (en) | 2011-06-23 |
| JP2014111654A (ja) | 2014-06-19 |
| WO2006000920A3 (en) | 2006-03-30 |
| JP2017134084A (ja) | 2017-08-03 |
| EP1778291B1 (en) | 2013-10-30 |
| WO2006000920A2 (en) | 2006-01-05 |
| ES2688796T3 (es) | 2018-11-07 |
| US20120207781A1 (en) | 2012-08-16 |
| US20080248059A1 (en) | 2008-10-09 |
| CN1976725B (zh) | 2012-08-29 |
| MX344621B (es) | 2017-01-03 |
| GB0413868D0 (en) | 2004-07-21 |
| CA2571565C (en) | 2014-08-12 |
| JP2008503716A (ja) | 2008-02-07 |
| EP2374473B1 (en) | 2018-07-18 |
| EP1778291A2 (en) | 2007-05-02 |
| CA2571565A1 (en) | 2006-01-05 |
| ES2443465T3 (es) | 2014-02-19 |
| BRPI0512281A (pt) | 2008-02-26 |
| NZ552449A (en) | 2010-05-28 |
| AU2005256961A1 (en) | 2006-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA06015198A (es) | Sistema de pantalla a color que ayuda a la seleccion y combinacion de colores. | |
| US6632093B1 (en) | Display system facilitating paint color selection and coordination | |
| RU2505867C2 (ru) | Система выбора цвета | |
| CA2549464C (en) | Method and system for arranging a paint color display | |
| US7187386B2 (en) | Paint color matching and coordinating system | |
| EP1115581B1 (en) | Color selection and identification for architectural coatings | |
| US20090021524A1 (en) | Color Selection System and Method | |
| WO2009009745A1 (en) | Color selection system | |
| US8363063B2 (en) | Color notation system | |
| Richter et al. | The story of the DIN color system | |
| Spence et al. | Using color to code quantity in spatial displays. | |
| US6139325A (en) | Device for determining color combinations | |
| CA2527065A1 (en) | Method for representing true colors with device-dependent colors on surfaces and for producing paints and coatings matching the true colors | |
| Neumann et al. | Computational color harmony based on coloroid system | |
| CN107532942A (zh) | 颜色分类系统 | |
| CA3220185A1 (en) | Method and system for generating display images of effect coatings | |
| CA2584540C (en) | Paint color matching and coordinating system | |
| CA2342466C (en) | Paint color matching and coordinating system | |
| Choudhury | Scales for communicating colours | |
| Yang et al. | Changes in perceived colors of cut roses under florist shop lighting | |
| CN102317759B (zh) | 色彩展示器及相关方法 | |
| Neumann et al. | Spectral Colour Order Systems and Appearance Metrics for Fluorescent Solid Colours | |
| JP2005258099A (ja) | カラーサンプル及びカラーサンプル帳 | |
| Rosenfeld | Light, Colour and Vision (Part I) | |
| Bradbury | Specification of cartographic layer tinting schemes for color graphic monitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |